Geistlich Bio-Oss® Portfolio Expands

Geistlich Biomaterials launches a new package size of Geistlich Bio-Oss® that provides increased therapy flexibility in regenerative dentistry.Introducing Geistlich Bio-Oss® 1 g -

PRINCETON, N.J., May 17, 2016 /PRNewswire/ -- Ever since its global market debut thirty years ago, Geistlich Bio-Oss®, a bone substitute utilized in periodontal and oral surgery procedures to regenerate lost bone in the oral cavity, has demonstrated clinical efficacy, long-term implant survival rates and predictability, all backed by scientific publications and investigations. "Geistlich Bio-Oss® 1 g meets the need for an extended product range! Additional flexibility in Guided Bone Regeneration (GBR) therapy for excellent long-term outcomes and stable esthetic results!" said Prof. Matteo Chiapasco from Milan, Italy. The addition of Geistlich Bio-Oss® 1 g provides a convenient new size that bridges the gap between small and large procedures.

Geistlich Bio-Oss®, derived from bovine bone, preserves the native crystalline structure, which is highly similar to human bone, through unique, patented technology. This manufacturing process ensures the vital building blocks are present to promote the initial biologic processes of cell adhesion and proliferation. The slow resorbing nature of Geistlich Bio-Oss® is a desirable characteristic providing long-term volume preservation. As the body recognizes and accepts these native crystalline structures, the particles become fully integrated into living bone.

To view this product being used in a surgical video, please click the link below.

The pairing of Geistlich Bio-Oss® with Geistlich Bio-Gide® in GBR treatments have been documented with clinical long-term success resulting in reliable 91.9% and 96% implant survival rates.1,2 In addition to GBR, Geistlich Bio-Oss® and Geistlich Bio-Gide® has demonstrated the preservation of facial bone walls after 5-9 years. 3,4

The new package size Geistlich Bio-Oss® 1 g is available in both small and large granule sizes.*

About Geistlich Pharma North America, Inc. -

Geistlich Pharma North America continues to lead dental regeneration with its expanding family of predictable and proven biomaterials, including bone substitutes Geistlich Bio-Oss® and Geistlich Bio-Oss Collagen®, a resorbable bilayer collagen membrane, Geistlich Bio-Gide®, a soft-tissue regeneration collagen matrix, Geistlich Mucograft®, and introducing, Geistlich Mucograft® Seal, a 3D collagen matrix designed for soft-tissue regeneration around an implant or prosthetic. With over 160 years of Swiss tradition, Geistlich Biomaterials has been a trusted partner for dental regenerative solutions based upon continuous innovation, scientific collaboration, and a commitment to successful outcomes.

1 Jung R. et al., Clin Oral Implants Res. 2013 Oct;24(10):1065–73
2 Aghaloo TL. and Moy PK., Int J Oral Maxillofac Implants. 2007;22 Suppl:49-70.
3 Buser D. et al., J Periodontol. 2013 Nov;84(11):1517-27. doi: 10.1902/jop.2013.120635. Epub 2013 Jan 24
4 Jensen S.S. et al., J Periodontol. 2014 Nov;85(11):1549-56
* Product availability can vary depending on the country

Photo - 
Logo - 

SOURCE Geistlich Pharma North America, Inc.